Sunday 21 July, 2019

UPDATE: Ministry amends drug recall

These are not what the Indapamide pills look like. This is a placeholder image. (FILE PHOTO)

These are not what the Indapamide pills look like. This is a placeholder image. (FILE PHOTO)

In an amended press statement issued moments ago, the Ministry of Health and Wellness has asserted that Natrilix has not been recalled locally.

The public is asked to note:

"The Barbados Drug Service has recalled another brand of the Valsartan drug, Citron branded Valsartan, along with Indapamide, because of the failure of both tablets to dissolve. This decision was made after testing was carried out by the Caribbean Public Health Agency (CARPHA) and is not related to the FDA recall."

The updated statement has replaced Natrilix with Indapamide.

The Ministry of Health and Wellness apologies for the inconvenience and possible panic or concern that the original press release issued earlier this morning, Saturday, January 5, 2019, may have inadvertently caused.

Besides that change from the Drug Service and Ministry, the information about the United States Food and Drug Administration recall of Valsartan not impacting Barbados remains.

See the full amended press release below:

Get the latest local and international news straight to your mobile phone for free: